港股异动 | 内险股集体上扬头部险企25年开门红产品陆续上市机构预计销售端良好态势仍将延续

智通财经12-06

智通财经APP获悉，内险股集体上扬，截至发稿，新华保险(01336)涨4.97%，报25.35港元；中国太保(02601)涨4.43%，报25.9港元；中国人寿(02628)涨3.6%，报15.52港元；中国平安(02318)涨2.19%，报46.7港元。招商证券指出，截至11月末头部险企2025年开门红产品已陆续上市，并在分红型增额终身寿和分红型年金上均有布局。同时考虑到保险公司可能在渠道佣金、...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2489426945?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-06 10:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2489426945","market":"us","top_or_hot":-1,"title":"港股异动 | 内险股集体上扬 头部险企25年开门红产品陆续上市 机构预计销售端良好态势仍将延续","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，内险股集体上扬，截至发稿，新华保险(01336)涨4.97%，报25.35港元；中国太保(02601)涨4.43%，报25.9港元；中国人寿(02628)涨3.6%，报15.52港元；中国平安(02318)涨2.19%，报46.7港元。招商证券指出，截至11月末头部险企2025年开门红产品已陆续上市，并在分红型增额终身寿和分红型年金上均有布局。同时考虑到保险公司可能在渠道佣金、...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1221238.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 内险股集体上扬 头部险企25年开门红产品陆续上市 机构预计销售端良好态势仍将延续</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 内险股集体上扬 头部险企25年开门红产品陆续上市 机构预计销售端良好态势仍将延续\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-06 10:54 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1221238.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，内险股集体上扬，截至发稿，新华保险(01336)涨4.97%，报25.35港元；中国太保(02601)涨4.43%，报25.9港元；中国人寿(02628)涨3.6%，报15.52港元；中国平安(02318)涨2.19%，报46.7港元。招商证券指出，截至11月末头部险企2025年开门红产品已陆续上市，并在分红型增额终身寿和分红型年金上均有布局。同时考虑到保险公司可能在渠道佣金、...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1221238.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1584","symbol_name":"蚂蚁金服概念","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1221238.html","article_id":"2489426945","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2489426945","pubTimestamp":1733453665,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"招商证券指出，截至11月末头部险企2025年开门红产品已陆续上市，并在分红型增额终身寿和分红型年金上均有布局。同时考虑到保险公司可能在渠道佣金、客户利益等方面对分红型产品进行差异化设置，以引导队伍销售和客户需求转变，该行预计分红险在头部险企2025年开门红的NBV占比有望接近一半。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"82318":"中国平安-R","601318":"中国平安","BK1584":"蚂蚁金服概念","IE00BVYPNQ40.USD":"GUINNESS ASIAN EQUITY INCOME \"C\" (USD) ACC","LU0348816934.USD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AT\" (USD)","LU0650527681.SGD":"Fidelity China Consumer A-SGD","LU1807302812.USD":"UBS (LUX) EQUITY SICAV ALL CHINA \"P\" (USD) ACC","HK0000306685.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) INC","LU0588545490.SGD":"Eastspring Investments - Asian Equity Income AS SGD","BK1507":"粤港澳大湾区","SG9999012744.USD":"UNITED ASIAN INCOME (USDHDG) INC","IE0032431581.USD":"PINEBRIDGE GREATER CHINA EQUITY \"A\" (USD) ACC","LU2226246903.HKD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AT4\" (HKD) ACC","03145":"华夏亚洲高息股","LU0228659784.USD":"施罗德金砖四国基金","LU0463099449.HKD":"SCHRODER ISF CHINA OPPORTUNITIES \"A\" (HKD) ACC","LU1251922891.USD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (USD) ACC","LU1769817179.HKD":"UBS (LUX) EQUITY SICAV - GLOBAL EMERG MARKETS OPPO \"P\" (HKD) INC","IE0008368742.USD":"首域中国增长基金I Acc","LU0084288322.USD":"Natixis Asia Equity RD USD","LU0862451753.SGD":"JPMorgan Funds - Emerging Markets Dividend A (mth) SGD","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","BK1136":"多元化保险","02601":"中国太保","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","IE00BZ08YS42.EUR":"GUINNESS BEST OF CHINA \"C\" (EUR) ACC","LU0384037296.USD":"ALLIANZ ASIAN MULTI INCOME PLUS \"AT\" (USD) ACC","LU1044874839.SGD":"THREADNEEDLE (LUX) ASIAN CONTRARIAN EQUITY \"AGH\" (SGDHDG) ACC","LU0611395673.USD":"NINETY ONE GSF EMERGING MARKETS EQUITY \"A\" (USD) ACC","LU2778985437.USD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"A\" (USD) INC","LU1282649067.USD":"ALLIANZ ASIAN MULTI INCOME PLUS \"AMG\" (USD) INC A","LU1282649810.SGD":"Allianz Asian Multi Income Plus Cl AMg DIS H2-SGD","LU0328353924.USD":"UBS (LUX) EQUITY SICAV - GLOBAL EMERGING MARKETS OPPORTUNITY (USD) \"P\" (USD) ACC","IE0003895053.USD":"PINEBRIDGE ASIA DYNAMIC ASSET ALLOCATION \"AD\" USD  ACC","SG9999004220.SGD":"Nikko AM Shenton Asia Dividend Equity Fund  SGD","LU0878005551.USD":"UBS (LUX) KEY SELEC ASIA ALLOCATION OPPORTUNITY (USD) \"P\" (USD) ACC","LU0054450605.USD":"HSBC GIF GLOBAL EMERGING MARKTS EQ \"AD\" INC","BK1184":"人寿与健康保险","LU0315178854.USD":"EASTSPRING INVESTMENTS ASIAN EQUITY INCOME \"A\" ACC","LU1044876610.USD":"THREADNEEDLE (LUX) ASIAN CONTRARIAN EQUITY \"ZU\" (USD) ACC","LU1642822792.SGD":"THREADNEEDLE (LUX) ASIAN CONTRARIAN EQUITY \"A\" (SGD) ACC","LU1226287529.USD":"UBS (LUX) KEY SELECTION SICAV - CHINA ALLOCATION  OPPORTUNITY (USD) \"P\" (USD) ACC","01336":"新华保险","LU0315179316.USD":"EASTSPRING INVESTMENTS ASIAN DYNAMIC \"A\" (USD) ACC","02318":"中国平安","LU0043850808.USD":"HSBC GIF ASIA EX JAPAN EQUITY \"AD\" INC","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU0918141887.USD":"安联亚洲实际收益股票基金","PNGAY":"中国平安ADR","02628":"中国人寿"},"translate_title":"Hong Kong stocks have changed, domestic insurance stocks have collectively risen, leading insurance companies have made a good start in 25 years, and products have been listed one after another. Institutions expect the good trend on the sales side to continue","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"82318":0.6,"601318":0.6,"02318":0.9,"02601":0.9,"02628":0.9,"01336":0.9,"PNGAY":0.6,"03145":0.6},"content_text":"智通财经APP获悉，内险股集体上扬，截至发稿，新华保险(01336)涨4.97%，报25.35港元；中国太保(02601)涨4.43%，报25.9港元；中国人寿(02628)涨3.6%，报15.52港元；中国平安(02318)涨2.19%，报46.7港元。招商证券指出，截至11月末头部险企2025年开门红产品已陆续上市，并在分红型增额终身寿和分红型年金上均有布局。同时考虑到保险公司可能在渠道佣金、客户利益等方面对分红型产品进行差异化设置，以引导队伍销售和客户需求转变，该行预计分红险在头部险企2025年开门红的NBV占比有望接近一半。国金证券认为，保险行业短期预计仍以贝塔驱动的行情为主，开门红NBV有望实现双位数增长将是超额收益的重要支撑。居民风险偏好整体偏低叠加储蓄需求强劲，且预定利率再次下调后，储蓄险的收益率仍优于银行定期存款且具备长期保值增值优势，预计销售端良好态势仍将延续，预计25年开门红新单保费仍有望实现正增长，NBV有望实现双位数增长。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2489426945"}

港股异动 | 内险股集体上扬 头部险企25年开门红产品陆续上市 机构预计销售端良好态势仍将延续

精彩评论

港股异动 | 内险股集体上扬头部险企25年开门红产品陆续上市机构预计销售端良好态势仍将延续